Postmenopausal Women
Three osteoporosis risk assessment tools underperform in younger postmenopausal women
Three risk assessment tools struggled to detect osteoporosis based on bone mineral density T-scores among women aged 50 to 64 years, researchers reported in a study published in JAMA Network Open.
Intentional weight loss of 5% or more cuts risk for death among postmenopausal women
Intentional weight loss of 5% or more, coupled with reduced waist circumference was associated with lower risk for death from cancer, CVD or any cause among postmenopausal women followed for more than 18 years, data show.
Prasterone may reduce UTI risk for postmenopausal women with vulvovaginal atrophy
Postmenopausal women with vulvovaginal atrophy treated with intravaginal prasterone for at least 12 weeks were nearly 50% less likely to develop a urinary tract infection compared with untreated women, researchers reported in Menopause.
Zoledronate infusions every 5 years may lower fracture risk for early postmenopausal women
Early postmenopausal women who receive zoledronate every 5 years have a lower risk for morphometric vertebral fractures than those receiving placebo, according to trial findings published in The New England Journal of Medicine.
Q&A: Multimorbidity in postmenopausal women ‘a new health challenge’
Women are living, on average, 5 years longer than men with an improved overall quality of life, but with an increased lifespan comes greater risk for multimorbidity, particularly after the menopause transition.
Top in women’s health: Contraceptive use after pandemic; misinformation spreads on TikTok
Data from a nationally representative web survey of fertility in the U.S. revealed that condom use declined following the COVID-19 pandemic, while other contraceptive use patterns remained stable.
Older age at natural menopause may increase asthma risk
Later age at natural menopause may be a risk factor for asthma, potentially due to prolonged estrogen exposure, data from a longitudinal study show.
Menopausal hormone therapy use fell 82% since 1999, as ‘negative perceptions’ persist
Hormone therapy use markedly declined among postmenopausal women of all ages, races and ethnicities in the U.S. during the past 2 decades, according to findings published in JAMA Health Forum.
Hormonal therapy use associated with later glaucoma diagnosis in postmenopausal women
Hormonal therapy may delay glaucoma onset in postmenopausal women, with longer duration of treatment linked to later diagnosis of glaucoma, according to a study in Investigative Ophthalmology & Vision Science.
Motivational interviews may improve sexual dysfunction during menopause
Among postmenopausal women with sexual dysfunction, motivational interviewing decreased sexual dysfunction while increasing sexual quality of life and sexual self-efficacy, researchers reported.